[Results of prolonged treatment of Parkinson's disease with the L-dopa-benserazide combination].
D000328:Adult; D000368:Aged; D001545:Benserazide / Q000627:therapeutic use*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007980:Levodopa / Q000627:therapeutic use*; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*
D004338:Drug Combinations; D006834:Hydrazines; D007980:Levodopa; D001545:Benserazide; D002262:Carboxy-Lyases
Risultati del trattamento prolungato del morbo di Parkinson con l'associazione L-Dopa plus Benserazide